Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04103619 · ClinicalTrials.gov registry record · NA
Energy-Based Lower Eyelid Rejuvenation - Proof of Concept for InMode AccuTite With or Without Morpheus8
A NA study of Periorbital Edema, sponsored by InMode MD.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 2
- Study locations
NCT04103619 is a NA study of Periorbital Edema that has completed, run by InMode MD. The registered enrollment target is 12 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT04103619, a NA study of Periorbital Edema, has completed, sponsored by InMode MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 2
- Study locations
Study Summary
1. To establish clinical efficacy, safety and patient satisfaction of reducing lower eyelid convexities or "bags" and/or malar crescents (festoons) with catheter-based injectable RF (InMode AccuTite) and variable depth Fractional RF Microneedle skin rejuvenation (InMode Morpheus8). 2. To determine the relative effectiveness of dual-modality treatment (AccuTite + Morphues8 initial treatment followed by two consecutive Morpheus8 treatments 1 month apart) versus single modality treatment (AccuTite only)
Conditions Studied
Interventions
- DEVICE AccuTite
- DEVICE AccuTite + Morpheus 8
Study Locations (2)
Florida
- David Holcomb - Sarasota
Ohio
- Gentile Facial Plastic and Aesthetic Laser Center - Youngstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-05-16 |
| Est. Completion | 2021-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04103619
The ClinicalTrials.gov registry entry for NCT04103619 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InMode MD, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Periorbital Edema appearing as the primary indexed condition, and to 2 interventions - of which AccuTite is the first listed.
NCT04103619 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Ohio.
Frequently Asked Questions
What is clinical trial NCT04103619 about?
NCT04103619 is a clinical study titled "Energy-Based Lower Eyelid Rejuvenation - Proof of Concept for InMode AccuTite With or Without Morpheus8". 1. To establish clinical efficacy, safety and patient satisfaction of reducing lower eyelid convexities or "bags" and/or malar crescents (festoons) with catheter-based injectable RF (InMode AccuTite) and variable depth Fractional RF Microneedle skin rejuvenation (InMode Morpheus8). 2. To determine t...
What is the current status of trial NCT04103619?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2019-05-16. Estimated completion is 2021-12-13.
What conditions does trial NCT04103619 study?
This clinical trial studies the following conditions: Periorbital Edema.
What interventions are being tested in trial NCT04103619?
The interventions under investigation include: AccuTite (DEVICE), AccuTite + Morpheus 8 (DEVICE).
Who is sponsoring clinical trial NCT04103619?
This trial is sponsored by InMode MD, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04103619 being conducted?
This trial has 2 study locations across Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Periorbital Edema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.